SCHEMBL27435355

SCHEMBL27435355

CC(C)(C)NCCc1cccc(-c2ccccc2F)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE8A O60658 1/20 0.38
GRM2 Q14416 1/20 0.37
ADORA2A P29274 4/20 0.36
ADORA3 P0DMS8 3/20 0.36
ADORA1 P30542 3/20 0.36
ADORA2B P29275 1/20 0.36
TRPV3 Q8NET8 1/20 0.36
PIM1 P11309 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
CTSA P10619 7/20 0.36
MAPT P10636 2/20 0.35
NPC1 O15118 2/20 0.35
MPL P40238 1/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22493432 0.84 GRM2 (0.36) GRM2ADORA2AADORA1ALDH1A1KDM4E
SCHEMBL22493438 0.83 CNR2 (0.43) CTSAGAASMN1; SMN2L3MBTL1MEN1
SCHEMBL22493894 0.79 SCN9A (0.44) TRPV3NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL22493472 0.77 TRPV3 (0.43) TRPV3MAPTKDM4EMEN1POLB
SCHEMBL22864062 0.74 PDE10A (0.43) ADORA2AMAPTNPC1ALDH1A1GAA
SCHEMBL22493739 0.74 PDE10A (0.49) TRPV3NPC1GAARAB9AKDM4E
SCHEMBL22480758 0.74 TRPV3 (0.39) ADORA3TRPV3CTSAMAPTNPC1
SCHEMBL22493866 0.73 CNR2 (0.39) TRPV3MAPTNPC1ALDH1A1RAB9A
SCHEMBL26856212 0.73 ADRB1 (0.41) GRM2ADORA2AADORA3ADORA1ADORA2B
SCHEMBL17886911 0.72 SMN1; SMN2 (0.46) ALDH1A1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137506-A1 COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS CURASEN THERAPEUTICS, INC. (US) 2024-06-27 WO disclosed